Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 199.20

+0.1%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Harrison Hickman who wrote (20290)	5/9/1998 6:20:00 AM
From: Henry Niman	Read Replies (1) of 32384

Actually, Legg Mason thinks that LGND needs more publicity and a string on news announcements. They project an $0.08 profit for next year. Here's their overview: Investment Summary We are initiating coverage of Ligand Pharmaceuticals, Inc. with Buy/Speculative risk ratings. Ligand's impressive platform technologies, strategic alliances, and lower risk business model have created one of the strongest product pipelines in the small and mid-size pharmaceutical arena. We feel that 1998 and 1999 will be pivotal years for the company as its first products reach the market, and others enter and advance through clinical trials. A consistent flow of news is something that the company has lacked in the past, and will need in the future to re-focus attention on it. We believe Ligand's upcoming milestones, including product launches, NDA and IND filings, and clinical data, should dramatically improve the company's visibility. Our confidence in the company appears to be shared by many in the pharmaceutical industry as pharmaceutical companies currently own approximately 25% of Ligand's outstanding shares.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next